AMAG Pharmaceuticals, Inc. announced earnings results for the second quarter ended June 30, 2020. For the second quarter, the company announced total revenue was USD 52.755 million compared to USD 77.767 million a year ago. Operating loss was USD 7.009 million compared to USD 116.185 million a year ago. Net loss was USD 13.244 million compared to USD 121.169 million a year ago. Basic loss per share from continuing operations was USD 0.39 compared to USD 3.58 a year ago. For the half year, total revenue was USD 123.200 million compared to USD 153.255 million a year ago. Operating loss was USD 24.801 million compared to USD 234.198 million a year ago. Net loss was USD 35.952 million compared to USD 243.569 million a year ago. Basic loss per share from continuing operations was USD 1.05 compared to USD 7.14 a year ago.